Journal of Medical Virology · 1995 · 28 citations · 15 references
Life SciencesImmunologyInfectious DiseasesMedical MicrobiologyMolecular VirologyVirologyAntigen Detection AssaysDonor ScreeningDonor-specific AntibodiesViral DiagnosticsViral HepatitisAgglutinationAgglutination ReactionsFalse Positive ReactionsHemagglutination AssaysHepatitis C InfectionHepatitis Virus DiagnosisHepatitis Virus TestingViral Hepatitis Assessment
Among 39,656 voluntary blood donors in Okinawa Prefecture, Japan, 115 (0.29%) were repeatedly reactive for antibody to hepatitis C virus (anti-HCV) by second generation (2nd-gen) passive hemagglutination assay (PHA). Positive serum samples were tested for anti-HCV using three different enzyme immunosorbent assays (ELISAs; Abbott 2nd EIA, UBI-HCV-EIA, JCC-2) and for HCV-RNA by the polymerase chain reaction (PCR). The 115 2nd-gen PHA-positive sera were divided into three groups according to the agglutination titers; > 2(10) (high titer group), 2(7)-2(9) (median), 2(5)-2(6) (low). All but one serum (44/45) in the high PHA titer group reacted in each of the three second screening ELISAs. Furthermore, 43 (97.7%) of the 44 sera contained HCV-RNA by PCR. In the median titer group, 11 of the 13 samples tested were positive by each of the three ELISAs, and 4 (36.4%) of the 11 showed reaction by PCR. On the other hand, all of the 38 sera tested in the low titer group were negative for HCV-RNA by PCR, and 24 of the 38 were also negative by each of the three ELISAs. Most of the low titer positive reactions in the 2nd-gen agglutination assay seemed to be false positive. In Okinawa Prefecture, the prevalence of anti-HCV among blood donors is much lower than in the rest of Japan (0.29% vs. 1.11%). Moreover, a significant proportion of these sera were low titer by the PHA assay.(ABSTRACT TRUNCATED AT 250 WORDS)
15
Hepatitis C Virus Infection in Post-Transfusion Hepatitis
Richard D. Aach, Cladd E. Stevens, F. Blaine Hollinger et al. · New England Journal of Medicine · 1991 · 531 citations · Full text
The 5'-terminal sequence of the hepatitis C virus genome.
Hiroaki Okamoto, S Okada, Y Sugiyama et al. · PubMed · 1990 · 484 citations
Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV
A. Albertí, Giulia Morsica, Liliana Chemello et al. · The Lancet · 1992 · 392 citations